Deep, focused future-era sequencing has unveiled that subclonal mutations (i.e., those current in only a fraction of tumor cells) is often detected for all driver genes and so are affiliated with speedy disease development and lousy end result.11–13 This is especially appropriate for TP53All this awareness has supplied new perspectives that are n